A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Lymphoma|Neoplasm|Prostatic Neoplasm
Interventions: DRUG: 7-hydroxystaurosporine (UCN-01)
Sponsor: National Cancer Institute (NCI)